Category Archives: Neurotechnology

The skull acts as a bastion of privacy; the brain is the last private part of ourselves, Australian neurosurgeon Tom Oxley says from New York.

Oxley is the CEO of Synchron, a neurotechnology company born in Melbourne that has successfully trialled hi-tech brain implants that allow people to send emails and texts purely by thought.

In July this year, it became the first company in the world, ahead of competitors like Elon Musks Neuralink, to gain approval from the US Food and Drug Administration (FDA) to conduct clinical trials of brain computer interfaces (BCIs) in humans in the US.

Synchron has already successfully fed electrodes into paralysed patients brains via their blood vessels. The electrodes record brain activity and feed the data wirelessly to a computer, where it is interpreted and used as a set of commands, allowing the patients to send emails and texts.

BCIs, which allow a person to control a device via a connection between their brain and a computer, are seen as a gamechanger for people with certain disabilities.

No one can see inside your brain, Oxley says. Its only our mouths and bodies moving that tells people whats inside our brain For people who cant do that, its a horrific situation. What were doing is trying to help them get whats inside their skull out. We are totally focused on solving medical problems.

BCIs are one of a range of developing technologies centred on the brain. Brain stimulation is another, which delivers targeted electrical pulses to the brain and is used to treat cognitive disorders. Others, like imaging techniques fMRI and EEG, can monitor the brain in real time.

The potential of neuroscience to improve our lives is almost unlimited, says David Grant, a senior research fellow at the University of Melbourne. However, the level of intrusion that would be needed to realise those benefits is profound.

Grants concerns about neurotech are not with the work of companies like Synchron. Regulated medical corrections for people with cognitive and sensory handicaps are uncontroversial, in his eyes.

But what, he asks, would happen if such capabilities move from medicine into an unregulated commercial world? Its a dystopian scenario that Grant predicts would lead to a progressive and relentless deterioration of our capacity to control our own brains.

And while its a progression that remains hypothetical, its not unthinkable. In some countries, governments are already moving to protect humans from the possibility.

In 2017 a young European bioethicist, Marcello Ienca, was anticipating these potential dangers. He proposed a new class of legal rights: neuro rights, the freedom to decide who is allowed to monitor, read or alter your brain.

Today Ienca is a Professor of Bioethics at ETH Zurich in Switzerland and advises the European Council, the UN, OECD, and governments on the impact technology could have on our sense of what it means to be human.

Before Ienca proposed the concept of neuro rights, he had already come to believe that the sanctity of our brains needed protection from advancing neurotechnology.

So 2015, around that time the legal debate on neurotechnology was mostly focusing on criminal law, Ienca says.

Much of the debate was theoretical, but BCIs were already being medically trialed. The questions Ienca were hearing six years ago were things like: What happens when the device malfunctions? Who is responsible for that? Should it be legitimate to use neurotechnology as evidence in courts?

Ienca, then in his 20s, believed more fundamental issues were at stake. Technology designed to decode and alter brain activity had the potential to affect what it meant to be an individual person as opposed to a non-person.

While humanity needs protection from the misuse of neurotech, Ienca says, neuro rights are also about how to empower people and to let them flourish and promote their mental and cerebral wellbeing through the use of advanced neuroscience and neurotechnology.

Neuro rights are a positive as well as protective force, Ienca says.

Its a view Tom Oxley shares. He says stopping the development of BCIs would be an unfair infringement on the rights of the people his company is trying to assist.

Is the ability to text message an expression of the right to communicate? he asks. If the answer is yes, he posits, the right to use a BCI could be seen as a digital right.

Oxley agrees with Grant that the future privacy of our brains deserves the worlds full attention. He says neuro rights are absolutely critical.

I recognise the brain is an intensely private place and were used to having our brain protected by our skull. That will no longer be the case with this technology.

Grant believes neuro rights will not be enough to protect our privacy from the potential reach of neurotech outside medicine.

Our current notion of privacy will be useless in the face of such deep intrusion, he says.

Commercial products such as headsets that claim to improve concentration are already used in Chinese classrooms. Caps that track fatigue in lorry drivers have been used on mine sites in Australia. Devices like these generate data from users brain activity. Where and how that data is stored, says Grant, is hard to track and even harder to control.

Grant sees the amount of information that people already share, including neuro data, as an insurmountable challenge for neuro rights.

To think we can deal with this on the basis of passing legislation is naive.

Grants solutions to the intrusive potential of neurotech, he admits, are radical. He envisages the development of personal algorithms that operate as highly specialised firewalls between a person and the digital world. These codes could engage with the digital world on a persons behalf, protecting their brain against intrusion or alteration.

The consequences of sharing neuro data preoccupies many ethicists.

I mean, brains are central to everything we do, think and say, says Stephen Rainey, from Oxfords Uehiro Centre for Practical Ethics.

Its not like you end up with these ridiculous dystopias where people control your brain and make you do things. But there are boring dystopias you look at the companies that are interested in [personal data] and its Facebook and Google, primarily. Theyre trying to make a model of what a person is so that that can be exploited.

Chile is not taking any chances on the potential risks of neurotechnology.

In a world first, in September 2021, Chilean law makers approved a constitutional amendment to enshrine mental integrity as a right of all citizens. Bills to regulate neurotechnology, digital platforms and the use of AI are also being worked on in Chiles senate. Neuro rights principles of the right to cognitive liberty, mental privacy, mental integrity, and psychological continuity will be considered.

Europe is also making moves towards neuro rights.

France approved a bioethics law this year that protects the right to mental integrity. Spain is working on a digital rights bill with a section on neuro rights, and the Italian Data Protection Authority is considering whether mental privacy falls under the countrys privacy rights.

Australia is a signatory to the OECDs non-binding recommendation on responsible innovation in neurotechnology, which was published in 2019.

Australian neuroscientist and ethicist Assoc Prof Adrian Carter, of Monash University, Melbourne, is described by peers as having a good BS detector for the real and imagined threats posed by neurotech. As a self-described speculative ethicist, he looks at the potential consequences of technological progress.

Hype that over-sells neuro treatments can affect their effectiveness if patients expectations are raised too high, he explains. Hype can also cause unwarranted panic.

A lot of the stuff that is being discussed is a long way away, if at all, says Carter.

Mind-reading? That wont happen. At least not in the way many imagine. The brain is just too complex. Take brain computer interfaces; yes, people can control a device using their thoughts, but they do a lot of training for the technology to recognise specific patterns of brain activity before it works. They dont just think, open the door, and it happens.

Carter points out that some of the threats ascribed to future neurotechnology are already present in the way data is used by tech companies every day.

AI and algorithms that read eye movement and detect changes in skin colour and temperature are reading the results of brain activity in controlled studies for advertising. This data has been used by commercial interests for years to analyse, predict and nudge behaviour.

Companies like Google, Facebook and Amazon have made billions out of [personal data], Carter points out.

Dystopias that emerge from the data collected without consent arent always as boring as Facebook ads.

Oxfords Stephen Rainey points to the Cambridge Analytica scandal, where data from 87 million Facebook users was collected without consent. The company built psychological voter profiles based on peoples likes, to inform the political campaigns of Donald Trump and Ted Cruz.

Its this line where it becomes a commercial interest and people want to do something else with the data, thats where all the risk comes in, Rainey says.

Its bringing that whole data economy that were already suffering from right into the neuro space, and theres potential for misuse. I mean, it would be naive to think authoritarian governments would not be interested.

Tom Oxley says he is not naive about the potential for bad actors to misuse the research he and others are doing in BCI.

He points out Synchrons initial funding came from the US military, which was looking to develop robotic arms and legs for injured soldiers, operated through chips implanted in their brains.

While theres no suggestion the US plans to weaponise the technology, Oxley says its impossible to ignore the military backdrop. If BCI does end up being weaponised, you have a direct brain link to a weapon, Oxley says.

This potential appears to have dawned on the US government. Its Bureau of Industry and Security released a memo last month on the prospect of limiting exports of BCI technology from the US. Acknowledging its medical and entertainment uses, the bureau was concerned it may be used by militaries to improve the capabilities of human soldiers and in unmanned military operations.

Concerns about the misuse of neurotech by rogue actors do not detract from what it is already achieving in the medical sphere.

At the Epworth centre for innovation in mental health at Monash University, deputy director Prof Kate Hoy is overseeing trials of neuro treatments for brain disorders including treatment-resistant depression, obsessive compulsive disorder, schizophrenia and Alzheimers.

One treatment being tested is transcranial magnetic stimulation (TMS), which is already used extensively to treat depression and was listed on the Medicare benefit schedule last year.

One of TMSs appeals is its non-invasiveness. People can be treated in their lunch hour and go back to work, Hoy says.

Basically we put a figure of eight coil, something you can hold in your hand, over the area of the brain we want to stimulate and then we send pulses into the brain, which induces electrical current and causes neurons to fire, she says.

So when we move [the pulse] to the areas of the brain that we know are involved in things like depression, what were aiming to do is essentially improve the function in that area of the brain.

TMS is also free of side effects like memory loss and fatigue, common to some brain stimulation methods. Hoy says there is evidence that some patients cognition improves after TMS.

When Zia Liddell, 26, began TMS treatment at the Epworth centre about five years ago, she had low expectations. Liddell has trauma-induced schizophrenia and has experienced hallucinations since she was 14.

Ive come a long way in my journey from living in psych wards to going on all sorts of antipsychotics, to going down this path of neurodiverse technology.

Liddell wasnt overly invested in TMS, she says, until it worked.

She describes TMS as, a very, very gentle flick on the back of your head, repetitively and slowly.

Liddell goes into hospital for treatment, normally for two weeks, twice a year. There shell have two 20-minute sessions of TMS a day, lying in a chair watching TV or listening to music.

She can remember clearly the moment she realised it was working. I woke up and the world was silent. I sprinted outside in my pyjamas, into the courtyard and rang my mum. And all I could say through tears was, I can hear the birds Mum.

It is a quietening of the mind that Liddell says takes effect about the three- to five-day mark of a two-week treatment.

I will wake up one morning and the world will be quiet Im not distracted, I can focus. TMS didnt just save my life, it gave me the chance of a livelihood. The future of TMS is the future of me.

But despite how it has changed her life for the better, she is not naive about the dangers of setting neurotech loose in the world.

I think theres an important discussion to be had on where the line of consent should be drawn, she says.

You are altering someones brain chemistry, that can be and will be life changing. You are playing with the fabric of who you are as a person.

Read more:

Our notion of privacy will be useless: what happens if technology learns to read our minds? - The Guardian

MAHWAH, N.J., Nov. 4, 2021 /PRNewswire/ --Stryker, one of the world's leading medical technology companies, continues to demonstrate its commitment to the United States military by working with VA and military hospital systems across the nation to provide innovative technology to those who care for veterans and individuals serving our country. Most recently, Stryker successfully completed Mako SmartRobotics placements in every VA hospital across one of the 18 Veterans Integrated Services Networks (VISNs), offering patients an advanced treatment option for knee and hip joint pain. This is the first VISN-level placement agreement Stryker has executed.

"Our team is comprised of 100% veterans, and we are truly passionate about advocating for our brothers and sisters to provide them with effective treatment options for joint pain," said John Murray, Senior Director, Government Sales, Stryker. "Our mission is to make Mako SmartRobotics the standard of care across VA and military hospitals throughout the nation."

Mako SmartRobotics is the only robotic platform that offers 3D CT-based planning, Accustop haptic technology, and insightful data analytics and has demonstrated better outcomes for total hip, total knee, and partial knee patients.1,2,3,4

"Over one in three veterans have arthritis5, one of the most common chronic conditions facing this population," said Murray. "Our team is honored to be able to provide these deserving patients with access to this advanced technology and a treatment option to help get them back on their feet and enjoying day-to-day activities."

Stryker's passion for supporting veterans and active military members is exemplified through a number of initiatives. Recently, Stryker announced a $55,474 donation to K9s For Warriors, the nation's largest provider of service dogs to American veterans living with military-related trauma. Through its "Own the Walk" initiative, Stryker partnered with Minor League Baseball (MiLB) and pledged to donate $1 for every walk issued to a batter during the 2021 regular season. Stryker has been a committed partner of K9s For Warriors since 2015, having sponsored 31 service dogs to date the largest number by any corporate partner.

It is important for those living with joint pain to speak with their healthcare professional about which treatment plans may be appropriate for them. To learn more about joint health treatment options, please visit makosmartrobotics.com.

All surgery carries risk. See your orthopaedic surgeon to discuss your potential benefits and risks. Not all patients will have the same postoperative recovery and activity level. Individual results vary.

About Stryker

Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available atstryker.com.

1.

Kayani B, Konan S, Tahmassebi J, Pietrzak JRT, Haddad FS. Roboticarm assisted total knee arthroplasty is associated with improved early functional recovery and reduced time to hospital discharge compared with conventional jig-based total knee arthroplasty: A prospective cohort study. Bone Joint J. 2018;100-B(7):930-937. doi:10.1302/0301-620X.100B7.BJJ-2017-1449.R1

2.

Mahoney O, Kinsey T, Mont M, Hozack W, Orozco F, Chen A. Can computer generated 3D bone models improve the accuracy of total knee component placement compared to manual instrumentation? A prospective multi-center evaluation. Poster presented at: 32nd Annual Congress of the International Society for Technology in Arthroplasty (ISTA); October 2-5, 2019; Toronto, Canada.

3.

Illgen RL, Bukowski BR, Abiola R, et al. Robotic-assisted total hip arthroplasty: outcomes at minimum two year follow up. Surg Technol Int. 2017;30:365-372.

4.

Kleeblad LJ, Borus T, Coon TM, Dounchis J, Nguyen JT, Pearle AD. Midterm survivorship and patient satisfaction of robotic-arm-assisted medial unicompartmental knee arthroplasty: a multicenter study. J Arthroplasty. 2018;33(6):1719-1726. doi:10.1016/j.arth.2018.01.036.

5.

https://www.cdc.gov/arthritis/communications/features/arthritis-among-veterans.html

SOURCE Stryker

Follow this link:

Stryker Expands Its Mako SmartRobotics Footprint To Reach More Veterans And Military Suffering From Joint Pain - PRNewswire

Last Price$ Last TradeChange$ Change Percent %Open$ Prev Close$ High$ low$ 52 Week High$ 52 Week Low$ Market CapPE RatioVolumeExchange

SYK - Market Data & News

Today, Stryker Corp. Incs (NYSE: SYK) stock gained $2.33, accounting for a 0.88% increase. Stryker opened at $266.13 before trading between $269.73 and $266.07 throughout Mondays session. The activity saw Strykers market cap rise to $101,212,639,405 on 1,224,359 shares -above their 30-day average of 1,079,667.

Stryker employs around 40000 people with a head office in Portage, Michigan.

Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.

Visit Stryker Corp.'s profile for more information.

Here's a trending selection from our newsletter, The Daily Fix, that captured readers' attention.Click hereto subscribe and get The Daily Fix delivered right to your inbox.

Sustainable Shoe Maker Allbirds Seeks IPO Valuation North of $2 Billion

Sustainable shoe brand Allbirds Inc is eyeing a valuation exceeding $2 billion in its US initial public offering (IPO).

In its amended Form S-1 filed Monday, the company said it is offering about 19.23 million shares priced between $12 and $14 apiece. At the high end of that range, Allbirds would fetch gross proceeds of over $269 million.

[More]

California Proposes Oil and Gas Drilling Buffer Zone Around Communities

California Gov. Gavin Newsom has proposed a statewide ban on oil and gas drilling within 3,200 feet of homes, schools and hospitals in order to protect public health and further its goal to combat climate change.

The draft rules, released last week by the states oil regulator California Geologic Energy Management Division (CalGEM), aim to create what would be the largest buffer zone in the country. Existing wells in those setback areas would not be banned, but subject to stricter regulation.

[More]

CDC Extends COVID-19 Safety Rules for Cruise Industry Through January 15

The US Centers for Disease Control and Prevention (CDC) extended its COVID-19 safety regulations for the cruise ship industry into January, citing concerns over the highly contagious Delta variant and breakthrough cases among fully vaccinated travelers.

Under the current measures, called a conditional sailing order, cruise lines have been permitted to operate as long as they adhere to certain precautions, such as requiring vaccinations or testing of crew and passengers as well as face masks onboard.

[More]

The New York Stock Exchange is the worlds largest stock exchange by market value at over $26 trillion. It is also the leader for initial public offerings, with $82 billion raised in 2020, including six of the seven largest technology deals. 63% of SPAC proceeds in 2020 were raised on the NYSE, including the six largest transactions.

To get more information on Stryker Corp. and to follow the company's latest updates, you can visit the company's profile page here: Stryker Corp.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE:The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

View post:

Stryker (SYK) gains 0.88% in Active Trading on November 1 - Equities.com

In September, Chile became the first state in the world to pass legislation regulating the use of neurotechnology. The neuro-rights law aims to protect mental privacy, free will of thought and personal identity.

The move comes amid both growing excitement and growing concern about the potential applications of neurotechnology for everything from defence to health care to entertainment.

Neurotechnology is an umbrella term for a range of technologies which interact directly with the brain or nervous system. This can include systems which passively scan, map or interpret brain activity, or systems which actively influence the state of the brain or nervous system.

Governments and the private sector alike are pouring money into research on neurotechnology, in particular the viability and applications for braincomputer interfaces (BCI) which allow users to control computers with their thoughts. While the field is still in its infancy, it is advancing at a rapid pace, creating technologies which only a few years ago would have seemed like science fiction.

The implications of these technologies are profound. When fully realised, they have the potential to reshape the most fundamental and most personal element of human experience: our thoughts.

Technological development and design is never neutral. We encode values into every piece of technology we create. The immensely consequential nature of neurotechnology means its crucial for us to be thinking early and often about the way were constructing it, and the type of systems we doand dontwant to build.

A major driver behind research on neurotechnology by governments is its potential applications in defence and combat settings. Unsurprisingly, the United States and China are leading the pack in the race towards effective military neurotechnology.

The USs Defense Advanced Research Projects Agency (DARPA) has poured many millions of dollars of funding into neurotechnology research over multiple decades. In 2018, DARPA announced a program called next-generation nonsurgical neurotechnology, or N3, to fund six separate, highly ambitious BCI research projects.

Individual branches of the US military are also developing their own neurotechnology projects. For example, the US Air Force is working on a BCI which will use neuromodulation to alter mood, reduce fatigue and enable more rapid learning.

In comparison to DARPAs decades of interest in the brain, Chinas focus on neurotechnology is relatively recent but advancing rapidly. In 2016, the Chinese government launched the China Brain Project, a 15-year scheme intended to bring China level with and eventually ahead of the US and EU in neuroscience research. In April, Tianjin University and state-owned giant China Electronics Corporation announced they are collaborating on the second generation of Brain Talker, a chip designed specifically for use in BCIs. Experts have described Chinas efforts in this area as an example of civilmilitary fusion, in which technological advances serve multiple agendas.

Australia is also funding research into neurotechnology for military applications. For example, at the Army Robotics Expo in Brisbane in August, researchers from the University of Technology Sydney demonstrated a vehicle which could be remotely controlled via brainwaves. The project was developed with $1.2 million in funding through the Department of Defence.

Beyond governments, the private-sector neurotechnology industry is also picking up steam; 2021 is already a record year for funding of BCI projects. Estimates put the industry at US$10.7 billion globally in 2020, and its expected to reach US$26 billion by 2026.

In April, Elon Musks Neuralink demonstrated a monkey playing Pong using only brainwaves. Gaming company Valve is teaming up with partners to develop a BCI for virtual-reality gaming. After receiving pushback on its controversial trials of neurotechnology on children in schools, BrainCo is now marketing a mood-altering headband.

In Australia, university researchers have worked with biotech company Synchron to develop Stentrode, a BCI which can be implanted in the jugular and allows patients with limb paralysis to use digital devices. It is now undergoing clinical human trials in Australia and the US.

The combination of big money, big promises and, potentially, big consequences should have us all paying attention. The potential benefits from neurotechnology are immense, but they are matched by enormous ethical, legal, social, economic and security concerns.

In 2020 researchers conducted a meta-review of the academic literature on the ethics of BCIs. They identified eight specific ethical concerns: user safety; humanity and personhood; autonomy; stigma and normality; privacy and security (including cybersecurity and the risk of hacking); research ethics and informed consent; responsibility and regulation; and justice. Of these, autonomy and responsibility and regulation received the most attention in the existing literature. In addition, the researchers argued that the potential psychological impacts of BCIs on users needs to be considered.

While Chile is the first and so far only country to legislate on neurotechnology, groups such as the OECD are looking seriously at the issue. In 2019 the OECD Council adopted a recommendation on responsible innovation in neurotechnology which aimed to set the first international standard to drive ethical research and development of neurotechnology. Next month, the OECD and the Council of Europe will hold a roundtable of international experts to discuss whether neurotechnologies need new kinds of human rights.

In Australia, the interdisciplinary Australian Neuroethics Network has called for a nationally coordinated approach to the ethics of neurotechnology and has proposed a neuroethics framework.

These are the dawning days of neurotechnology. Many of the crucial breakthroughs to come may not yet be so much as a twinkle in a scientists eye. That makes now the ideal moment for all stakeholdersgovernments, regulators, industry and civil societyto be thinking deeply about the role neurotechnology should play in the future, and where the limits should be.

Read more:

The big promises and potentially bigger consequences of neurotechnology | The Strategist - The Strategist

BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker Corporation (NYSE:) on Thursday, setting a price target of $284, which is approximately 5.77% above the present share price of $268.5.

Zimmerman expects Stryker Corporation to post earnings per share (EPS) of $1.57 for the fourth quarter of 2021.

The current consensus among 5 TipRanks analysts is for a Strong Buy rating of shares in Stryker, with an average price target of $301.75.The analysts price targets range from a high of $320 to a low of $284.

In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $4.29 billion and a net profit of $808 million. The company's market cap is $101.25 billion.

According to TipRanks.com, BTIG analyst Ryan Zimmerman is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 23.9% and a 56.41% success rate.

Michigan-based Stryker Corp. was founded in 1941. The company provides medical technology products and services. It operates its business through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Read the original here:

BTIG Stick to Their Buy Rating for Stryker Corporation By Investing.com - Investing.com

Otology Drills Market Introduction

Otology drill is a surgical equipment primarily used during otologic procedures. Otology drills are available with different operating speeds, ranging from 16,000 rpm to 85,000 rpm, as per the need and requirement of otologic procedure. These drills feature straight and angled attachments to achieve desired flexibility, surgical access & visibility, and irrigation systems, and are power driven. These are available in different types of surgical bur attachments to serve required purpose of otology surgeries.

Read Report Overview - https://www.transparencymarketresearch.com/otology-drills-market.html

Global Otology Drills Market - Competitive Landscape

The global otology drills market is consolidated, with small number of players holding majority share in respective regions. New product development & commercialization and mergers & acquisition are the key trends observed in the global otology drills market.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=71742

Medtronic plc

Medtronic plc is a diversified medical device company engaged in the manufacture of a range of medical devices & technologies. The company develops and markets products and therapies in the areas of cardiac rhythm disorders, cardiovascular diseases, neurological disorders, spinal conditions, ENT surgeries, and diabetes. It operates business through four functional divisions: Cardiac & Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The company offers four different types of otology drills in its product portfolio: Indigo Otology Drills, Visao High-Speed Otologic Drill, and Midas Rex Legend Stylus Surgical Drills.

Request for Analysis of COVID-19 Impact on Otology Drills Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=71742

Stryker Corporation

Stryker Corporation is a global medical devices company that operates through three business segments: orthopedics, MedSurg, and neurotechnology & spine. The company is a leading player in the medical devices industry. It offers a range of products such as implants employed in orthopedic, trauma, and replacement surgeries; endoscopic and communication systems; emergency medical equipment and intensive care disposable products, and surgical equipment & surgical navigation systems. The company offers S2 Drive Drill and S2 Mini Drill System in the otology drills market.

DePuy Synthes

DePuy Synthes is a part of Johnson & Johnsons medical device segment. The company offers joint reconstruction solutions for knee, hip, and shoulder joints. DePuy Synthes offers a range of solutions addressing key areas of spine surgery such as cervical, thoracolumbar, ENT surgery, aging spine, minimally invasive surgery, and interbody fusion. The company operates across the world through its direct sales force, independent sales agents, and distributors. The company offers ANSPACH EMAX 2 Plus System and Anspach High Speed Drill System in the otology drills market.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=71742

CONMED Corporation

CONMED Corporation is a global medical technology company engaged in the development, manufacture, and marketing of surgical and patient-monitoring devices for minimally invasive procedures. The companys products and technologies have wide usage in the following medical specialties: orthopedics, laparoscopy, robotic and open surgery, gastroenterology & pulmonology, cardiology, ENT surgery, and critical care. CONMED Corporation operates through three business segments: orthopedic surgery, general surgery, and surgical visualization.

Other leading players operating in global otology drills market include Olympus Corporation, NOUVAG AG, KARL STORZ, SPIGGLE & THEIS Medizintechnik GmbH, and Bien-Air Surgery SA.

Pre Book Otology Drills Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=71742&ltype=S

Otology Drills Market - Dynamics

High Prevalence and Incidence Rates of Hearing Loss to Drive Market

The global otology drills market is primarily driven by high prevalence of hearing loss. According to the Hearing Loss Association of America (HLAA), hearing loss is considered to be the third most common physical condition after arthritis and heart disease, affecting people of all ages. Gradual hearing loss can affect people of all ages differing from mild to profound. It can be mild or severe, temporary or permanent, depending on the cause. According to the WHO, a person who is unable to hear as well as someone with normal hearing hearing thresholds of 25 dB or better in both ears is considered to have hearing loss. Moreover, in 2019, nearly 466 million people across the world are likely to have disabling hearing loss. Among them, 93% are anticipated to be adults and 7% children. Among adults, more men (56%) than women (44%) are expected to have disabling hearing loss. Hence, high prevalence of hearing loss is projected to fuel the growth of the global otology drills market during the forecast period.

Technological advancements in the development of otology drills, such as high speed otology drills, compatibility of different sized otology burs, and development of integrated power systems are anticipated to boost the growth of the market during the forecast period.

More Trending Reports by Transparency Market Research:

Oncolytic Virus Immunotherapy Market Due to advancements in medical science and technology, at present, immunotherapy is at the helm of modern oncology care due to which, the deployment of oncolytic virus immunotherapy has witnessed consistent growth.

Urodynamics Equipment and Disposables Market Urodynamic testing forms the foundation of investigation pertaining to lower urinary tract dysfunction. However, amidst the COVID-19 (coronavirus) pandemic, healthcare providers are adapting to new urodynamics procedures to establish quality control in healthcare settings.

Hepatitis E Diagnostic Tests Market The growth of hepatitis E diagnostic tests market in Latin America is expected to be modest, owing to the hyper-endemicity of the disease in certain regions and the growing tourism, leading to the movement of people from hyper-endemic and endemic regions to non-endemic regions.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

ContactMr. Rohit BhiseyTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.comWebsite: https://www.transparencymarketresearch.com/

Visit link:

Otology Drills Market: High Prevalence and Incidence Rates of Hearing Loss to Drive Market - BioSpace

This article originally appeared in issue 21of IT Pro 20/20,available here. To sign up to receive each new issue in your inbox,click here

COVID-19 has created an unprecedented shift in the way we work, forcing millions to leave the workplace behind in favour of cobbled together home office spaces and virtual meetings. While this transition was disruptive at first, Ernst & Young research reveals nine in ten employees want the flexibility its brought to continue post-pandemic. This has led many organisations to embrace a hybrid approach, whereby employees split their time between home and the workplace.

Its clear, however, that offices need to adapt as people prepare to return. As a result of remote working, employees have enjoyed clear productivity benefitsfuelled by technologies such as video conferencing and cloud-based collaboration software. Many will also fear a return to twice-daily commutes and in-person meetings could cause them to feel burned out so solutions will need to be employed to ensure employees dont resent returning to the office.

One way to project what the office of the future will look like is to understand peoples remote work experiences over the last 18 months. According to Hyperoptic, the future of the workplace is technology-driven, with nearly two thirds of Brits (59%) saying theyd like to see new technologies introduced into their offices within the next 12 months. More specifically, 20% are calling for more Internet of Things (IoT) tech, 14% for 3D printing and 13% for virtual reality (VR) teleconferencing devices.

Zoom and Microsoft Teams enjoyed unparalleled success during the pandemic and quickly became household names. Employees, however, are beginning to tire of these tools, with Microsoft CEO Satya Nadella even warning of the risk of video call fatigue caused by back-to-back meetings. To combat this growing issue, businesses need conferencing tools that better engage their hybrid workforce, according to Dennis Shafranik, a partner at investment firm Concentric.

Zoom-esque solutions are still not that great or engaging, are tiring for people to use, and dont translate context or emotions.This makes it tough to build lasting trust through, Shafranik tells IT Pro. A cool example of technology that could transform video conferencing is Googles pilot, Project Starline, which creates a live, 3D video-image of a remote colleague, and comes much closer to recreating a true in-person meeting.

A variety of telepresence and telerobotics are also being developed, to enable workers to feel physically within a space alongside their colleagues. An example is Double Robotics, which is essentially an iPad on a robotic arm, and too expensive for most businesses at present. However, in the coming years, well see developments to improve these innovations, to make them more affordable and efficient. And there is certainly an opportunity in the market, with organisations looking to boost home productivity now normal office life has resumed.

Shaping the workplace of the future

Businesses must cater for the data demands of mobile, social and the IoT without disrupting day-to-day operations or security...

Narinder Sahota, CTO at IT company Advanced, agrees, adding that attempts to foster a virtual employee experience, be it through Teams or Slack, has rapidly turned into an app overload nightmare, with innovative technologies required to make the experience more personal. People, at the moment, are struggling to distinguish the wood from the trees.

As such, he continues, we are going to see businesses simplify and personalise technology in the workforce. Were already seeing Google test its ideas for the office of the future with its prototype hot desk of the future, with desks that adjust to a users personal preferences, as well as 3D meetings and inflatable privacy walls made of cellophane.

This app overload nightmare is also causing employees to burn out; an issue only set to get worse as they return to the workplace. Dr Jamil El Imad, chief scientist at NeuroPro, believes his Dream Machine a VR system that uses advanced signal processing techniques to monitor the brain and other bio-data could be the answer. After recognising the potential of VR, he worked on using cloud computing to capture and analyse brain activity. The end result is a machine that simulates the meditation experience.

I believe the future offices primary function is to heal and to re-humanise the work environment and entrench a culture of compassion and individuality, El Imad tells IT Pro. The deeper we connect not only with our minds but with our hearts too, the more motivated and empowered we become to outperform.

His Dream Machine reads neural activity in real-time and curates a natural experience that reflects a users changing state of mind. Its a mind gym, El Imad explains, designed to help us focus in a fun way using VR and neurotechnology. One example involves beaming a user to a tropical island. The mission, in this exercise, is to use the power of the mind to clear the heavy fog on the island; only by concentrating can you clear the fog and enjoy the natural beauty. Essentially, he says, youre rewarded with a feeling of weightlessness by relaxing and breathing naturally. Following this exercise, users receive a performance score based on how well they concentrated and how relaxed they were.

We know that wellness, physical and mental, is key to performance and resilience is key to prevention. We also know that mental resilience can be trained so its time we pay attention to our mind and lift our mental resilience to help us cope better in this fast changing, uncertain world.

Office-based workers arent the only ones set to see technology change the way they work. Innovation will also revolutionise so-called deskless jobs such as those held by nurses, cleaners and field engineers which currently still rely on paper-based checklists and outdated spreadsheets.

Kit Kyte, CEO of workflow software firm Checkit, tells IT Pro that although headlines claim most workers want a split between office and home working, the reality is most employees work neither at an office nor at home. In fact, 80% of working people are deskless, he says. All the talk of hybrid models, video-conferencing and file sharing is lost on that population because theyve been excluded from the digital conversation. But theres a groundswell of change. Businesses are starting to recognise the impact deskless workers have on overall productivity, customer experience, safety standards, efficiency and waste reduction. Those that are digitally enabling their deskless workers and connecting disparate data sources will have an advantage in the future.

Kyte adds well move from command-and-control structures to allowing frontline teams to make data-driven decisions. Staff will also have greater autonomy, instead of following paper-based checklists. Cleaners, for example, wont slavishly follow hourly schedules, rather theyll be prompted to attend sites based on footfall data from smart building systems. Theyll no longer work in isolation but as part of a wider digital ecosystem, with innovative businesses combining IoT and automation with digital assistants to eradicate dark operations.

Steve Black, co-founder and chief strategy officer of Topia, even believes that such technologies could create deskless jobs from those currently in office-based roles. We expect to see a future of work where flexible working takes on an entirely new meaning. In that world expect to see fluid global teams, with rapidly changing footprints and a wider scope of mobility, he tells IT Pro. Teams will form around a specific role or task for a company, so for a certain time period individuals will be plugged into an organisation but may then leave once the task is completed and move onto a different team or role.

Consequently, headquarters will shrink with more satellite offices popping up as they embrace location agnostic teams with sophisticated talent and project management software that will use AI and predictive analytics to proactively identify market opportunities, then assign resources. So rather than flexiwork it will become a flexi-task workforce. Employees will be attracted to a role or assignment because of the fulfilment it offers and the experience and career opportunities it offers. For governments and employers this will mean an even bigger focus on connectivity, local facilities to meet-up and having the right tools to collaborate, but also they will need to understand where we live will be more determined by quality of life than what job opportunities it might offer.

Next-generation time series: Forecasting for the real world, not the ideal world

Solve time series problems with AI

The future of productivity

Driving your business forward with Microsoft Office 365

How to plan for endpoint security against ever-evolving cyber threats

Safeguard your devices, data, and reputation

A quantitative comparison of UPS monitoring and servicing approaches across edge environments

Effective UPS fleet management

View post:

How the pandemic has shaped the office of the future - IT PRO

The round table Neurotechnologies and Human Rights framework: Do we need new rights? will take place online on 09 November 2021 (10.00 17.00 CET).

The event is co-organised by the Council of Europe and the OECD, with the participation of UNESCO. It is held in the context of the launch of the Council of Europe Strategic Action Plan on Human Rights and Technologies in Biomedicine (2020-2025) and the implementation of the 2019 OECD Recommendation on Responsible Innovation in Neurotechnology.

The discussion of the round table will tackle the most pertinent questions raised with application of neurotechnologies in medical and non-medical fields from the standpoint of human rights, such as privacy, freedom, integrity and non-discrimination.

More information is available on the event, including Report of the Council of Europe on Common Human Rights Challenges raised by Different Applications of Neurotechnologies in the Biomedical Field, the Programme of the event, and the Registration form.

The round table will be open for public upon registration done before 07 November 2021.

More information:

Follow us on social media:

Original post:

Neurotechnologies and Human Rights framework: Do we need new rights? - Council of Europe

image:Illinois Institute of Technology Professor of Biomedical Engineering Philip Troyk view more

Credit: Illinois Institute of Technology

During a visit to Illinois Institute of Technologys Mies Campus in Chicago, Governor J. B. Pritzker announced that the State of Illinois would be providing $1.5 million to the Pritzker Institute of Biomedical Science and Engineering at Illinois Institute of Technology (Illinois Tech) to renovate 2,770 square feet of existing Illinois Tech wet lab space to create a specialized multi-tenant laboratory called the Neurotissue and Organoid Innovation Laboratory (NOIL) for advanced research in translational neurotechnology.

Our state is a national hub for entrepreneurship and innovation because of leaders like Illinois Tech paving the way forward for the talent and technology of tomorrow. The more that we can do to support your mission here at Illinois Tech, the better off well all be in the state of Illinois and in the United States, says Pritzker. This investment creates opportunities to advance IITs research and to provide a range of much-needed scientific, regulatory, and business development services to startups investing in cutting-edge research.

Pritzker selected Illinois Tech as one of eight wet labs across the state to receive funding through the Rebuild Illinois Wet Lab Capital Program, and Illinois Tech will match the $1.5 million that the state provided.

Pritzker says he believes this funding for Illinois Tech serves as an investment not just in the university but in its broader community, which includes its partner institutions such as Malcolm X College, whose representatives attended the governors announcement.

Todays grants are an exemplification of what happens when a very supportive government helps higher ed do what it does best by bringing people together and by doing cutting-edge research that solves the grand challenges of our times while at the same time empowering diverse learners with the skills so that they can thrive in the future world, says Raj Echambadi, president of Illinois Tech.

NOIL will offer researchers, medical startups, and companies across the country access to advanced equipment and facilities to conduct fundamental studies supporting the development of novel medical therapies.

Our goal for the laboratory is to enhance the state of Illinoiss regional capabilities to attract, support, and facilitate growth of small businesses, startups, entrepreneurs, and university collaborators who are part of a rapidly growing neurotech sector, says Executive Director of the Pritzker Institute, Robert A. Pritzker Endowed Chair in Engineering, and Professor of Biomedical Engineering Philip Troyk. From state-of-the-art visual prosthetics to Illinois Techs brain atlas project, this new facility will allow Illinois Tech and the state of Illinois to play a central role in the development of truly life-changing biomedical advances.

NOIL is a crucial component of the newly formed Functional Neural Technology Center, which will provide one-stop-shop services to growing companies, entrepreneurs, and emerging academic collaborations that are pursuing cutting-edge clinical translation in the field of neurotechnology.

The renovated wet lab will provide the facilities essential to advance the development of neural implant technology such as the world-leading visual prosthesis developed at Illinois Tech. It will also serve the emerging field of bioelectronic medicine, which promises to substitute traditional drug therapies by creating implanted neural-modulation medical device interfaces to nerves that control human organs.

The remodeling of wet labs for specialized neural tissue and organoids will provide new fundamental and functional wet laboratory space for multiple users and create an unprecedented capability within Chicago for the support of collaborative neural technologies research.

Troyk, who has developed a first-of-its-kind visual prosthesis system, says, Making that transition from an idea to a clinical deployment is not easy. Illinois Tech is launching an initiative that will assist those who are developing these novel therapies in order to navigate the pathway from concept to clinic.

As part of the Illinois Tech and City Colleges of Chicago partnership, Malcolm X College will provide its students with opportunities to learn and conduct research in the renovated wet lab space.

David Sanders, president of Malcolm X College, says, Illinois Tech has a history of working with City College faculty to develop transfer agreements and offering City College students generous scholarships. Our involvement in the wet lab research space is the next step in our powerful, powerful relationship.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Read the rest here:

Illinois Tech awarded state government funding to develop the Neurotissue and Organoid Innovation Laboratory - EurekAlert

Sens.ai has built heart coherence training into its breakthrough neurofeedback system to help reduce record stress levels and increase happiness

WHISTLER, B.C., Oct. 21, 2021 /PRNewswire-PRWeb/ -- Sens.ai, a personalized neurotechnology company, will soon launch its wearable headset that utilizes a Pulse Oximeter sensor to treat stress by not only measuring heart rate variability (HRV) but also training it. Sens.ai uses a headset and app to read heart signals and translate them into audiovisual cues, acting like a mirror for the mind and heart. Sens.ai's personalized training approach is supported by decades of research and clinical work on increasing physiological adaptability and mental wellbeing.

Sens.ai is arriving at an optimal time, slated for consumer launch in Q2 2022. According to the American Psychological Association, American adults report feeling more stressed today than ever before. 47% of adults have reported feeling anxiety, 44% feel sadness, and 39% feel extreme anger. Additionally, 67% of adults said the number of issues America is facing is overwhelming to them.

Sens.ai's innovative headset is designed to bring a full suite of clinically-developed neuro training to the consumer in the comfort of their own home, and into the palm of their hands. The system both trains and stimulates the central nervous system through audiovisual cues and light therapy, with real-time reading and adapting to both the heart and brain's activity. Sens.ai's unique brain and heart workout clears brain fog, helps calm your nervous system for sound sleep and builds memory capacity.

"We believe that through Sens.ai, anyone can finally have access to world-class neuro-optimization technology in the comfort of their own home and at an approachable cost," said Paola Telfer, CEO, and founder of Sens.ai. "One of the many benefits of Sens.ai is the ability to reduce stress and increase happiness. Many people struggle to reduce stress levels quickly and long term. This is where Sens.ai comes into play, utilizing personalized HRV and neurofeedback training technology; it empowers people to quickly summon calm when they feel stress and more importantly, train calm as a long-term, substance-free habit. "

Story continues

Managing their stress response allows people to perform better and increase happiness. Heart rate variability training, is also referred to as heart coherence training. This state of heart coherence occurs when your heart rate smoothly moves up and down like the rise and fall of a wave. This state of heart coherence is incredibly peaceful and calming. A high HRV is a known indicator of a flexible and balanced central nervous system.

Training with Sens.ai not only helps users increase their HRV over time but can also teach them how to enter a state of heart coherence. The HRV training can be used on its own, or as a primer to improve the brain's response to a neurofeedback session. By using Sens.ai's programs, the mind-body connection and overall cognitive function will be strengthened.

To learn more, please visit http://www.sens.ai.

About Sens.ai Sens.ai is an adaptive brain training system designed to help people rewire their brain for peak performance in the comfort of their own home. Through its innovative headset, packed with technological innovations, the system provides real-time feedback to continually personalize training and challenge the mind's potential. Sens.ai has the unique ability to provide objective functional testing from home so you can track changes as you expand your mental flexibility and awaken your genius. For more information visit http://www.sens.ai.

Media Contact

Elyse Johnson, Sens.ai, 6202023037, pr@sens.ai

SOURCE Sens.ai

See the article here:

Sens.ai is The First At-Home Neuro-Optimization System to Incorporate Heart Coherence Training With Brain Training to Help People Manage Stress -...